Sanofi India Limited
Nippon India Mutual Fund raised its stake in Sanofi India from 4.08% to 4.17%, buying 20,890 shares.
A leading multinational pharmaceutical company operating in India, Sanofi India manufactures and distributes medicines across multiple therapeutic areas including diabetes, cardiology, thrombosis, central nervous system disorders, and anti-histamines. The company serves patients and healthcare providers through a comprehensive portfolio of pharmaceutical products designed to address diverse medical conditions. Its established presence in India's pharmaceutical market reflects its commitment to improving health outcomes across the country.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.